Glutamate and schizophrenia beyond the dopamine hypothesis

Glutamate And Schizophrenia Beyond The Dopamine Hypothesis, The development of glutamatergic antipsychotics is still in  Автор: M Laruelle · 2014 · Цитируется: 278 — Many lines of evidence suggest that schizophrenia is associated with excessive stimulation of dopamine D2 receptors in the associative striatum, with a lack of  The glutamate and dopamine hypotheses are leading theories of the pathoaetiology of schizophrenia. Schizophrenia by Robert Sapolsky. We also review the NMDA  Disturbances in glutamate transmission and NMDA receptor hypofunction are associated with schizophrenia. Автор: G Tsai · 2002 · Цитируется: 808 — Several clinical trials indicate agents that enhance NMDA receptor function via the glycine modulatory site reduce negative and variably improve cognitive  Автор: J Kumar · 2020 · Цитируется: 202 — Inflammation is associated with increased glutamate, whereas the antioxidant glutathione may protect against inflammation-induced oxidative  Comments ; The Role of Glutamatergic Signaling in Major Depressive Disorder. Cortical and  Автор: DC Javitt · 2012 · Цитируется: 144 — At present, all medications for schizophrenia function primarily by blocking dopamine D2 receptors. With continued advancements, glutamate modulation has the potential to transform schizophrenia treatment, particularly for cognitive and  The glutamate hypothesis of schizophrenia posits that the disorder may be at least partially caused by deficient activity at glutamate synapses, which may in  Автор: P Seeman · 2009 · Цитируется: 101 — Hence, the clinical antipsychotic action of a glutamate agonist may depend on its ability to interfere with DA neurotransmission by its DA partial agonism. Recent discoveries extend our  Автор: A de Bartolomeis · 2005 · Цитируется: 72 — The hypofunction of the ionotropic glutamate N-methyl-D-Aspartate Receptor (NMDA-R) has been proposed as a model of schizophrenia in humans. 2020. Over 50 years ago, the first observations were made that  Dopamine (DA) and glutamate neurotransmission are strongly implicated in schizophrenia pathophysiology. These theories originated over 20  Автор: RA McCutcheon · 2020 · Цитируется: 886 — Converging evidence indicates that genetic and environmental risk factors for schizophrenia underlie disruption of glutamatergic and dopaminergic function. Автор: M Laruelle · 2003 · Цитируется: 662 — In conclusion, it is proposed that schizophrenia is associated with strongly interconnected abnormalities of GLU and DA transmission: NMDA hypofunction in the  Glutamate hypothesis in schizophrenia. Humans; Receptors, Dopamine / metabolism; Receptors, Glutamate / metabolism*; Schizophrenia / etiology*; Schizophrenia  Автор: JM Stone · 2007 · Цитируется: 569 — We examine predictions made by the NMDA receptor hypofunction hypothesis and consider how they fit with current neurochemical findings in patients and animal  schizophrenia remain unknown. Over 50 years ago, the first observations were made that  The dopamine hypothesis of schizophrenia is the principal explanatory model of antipsychotic drug action. Автор: B Moghaddam · 2011 · Цитируется: 1415 — Glutamatergic theories of schizophrenia are based on the ability of N-methyl--aspartate receptor (NMDAR) antagonists to induce schizophrenia-  The Glutamate Hypothesis: A Key to Understanding Schizophrenia The Glutamate Hypothesis suggests that schizophrenia is fundamentally driven by  Автор: RA McCutcheon · 2020 · Цитируется: 886 — Glutamate and dopamine systems play distinct roles in terms of neuronal signalling, yet both have been proposed to contribute significantly  Автор: A Hasan · 2014 · Цитируется: 31 — To sum up, one could note that the glutamate hypothesis of schizophrenia is now well-established. Автор: DC Javitt · 2012 · Цитируется: 144 — At present, all medications for schizophrenia function primarily by blocking dopamine D2 receptors. HMP Global · 89K views ; 30. Schizophrenia Showdown: Dopamine or  Автор: O Howes · 2015 · Цитируется: 1130 — The glutamate and dopamine hypotheses are leading theories of the pathoaetiology of schizophrenia. The NMDA hypofunction hypothesis originates mainly from indirect pharmacological  Автор: K Hashimoto · 2002 · Цитируется: 14 — A dysfunction of glutamatergic neurotransmission may play an important role in the pathophysiology of schizophrenia. @article schizophrenia, and opens new avenues for targeted treatment strategies beyond the dopaminergic model. The drug PCP acts on glutamate receptors, producing schizophrenia-like  Автор: LC Huang · 2020 · Цитируется: 16 — This hypothesis implies that higher glutamatergic concentration in the brain with normalized or decreased dopamine synthesis capacity may explain aspects of TRS  There is growing evidence that two neurotransmitters - dopamine and glutamate - are abnormal in people with psychotic illness, including  This paper critically evaluates the extent to which the dopamine and glutamate hypotheses provide different explanations for the positive,  Автор: JM Stone · 2007 · Цитируется: 569 — In this review, we study the evidence for dopaminergic dysfunction in schizophrenia, drawing data from neurochemical imaging studies. The development of glutamatergic antipsychotics is still in  The glutamate hypothesis of schizophrenia, proposed over two decades ago, originated following the observation that administration of drugs that block NMDA  Автор: T Swanton · 2020 · Цитируется: 9 — This essay explores hypotheses postulating that the neurotransmitters dopamine, glutamate, and gamma-aminobutyric acid (GABA) cause schizophrenia,  The glutamate hypothesis may better explain negative and cognitive symptoms compared to the dopamine hypothesis. Treatment studies  Автор: RA McCutcheon · 2020 · Цитируется: 808 — Glutamate and dopamine systems play distinct roles in terms of neuronal signalling, yet both have been proposed to contribute significantly  Glutamate-based theories of schizophrenia focus on dysfunction of brain glutamate systems, particularly NMDA receptors. In this review, the glutamate hypothesis of  Автор: DC Javitt · 2012 · Цитируется: 144 — At present, all medications for schizophrenia function primarily by blocking dopamine D2 receptors. Javitt, D. We also review the NMDA  Professor Jeffrey Lieberman discusses the glutamate hypothesis of schizophrenia. Автор: B Moghaddam · 2012 · Цитируется: 1415 — Glutamatergic theories of schizophrenia are based on the ability of N-methyl-D-aspartate receptor (NMDAR) antagonists to induce schizophrenia-like symptoms, as  Автор: O Howes · 2015 · Цитируется: 1130 — The glutamate and dopamine hypotheses are leading theories of the pathoaetiology of schizophrenia. While most studies focus on contributions of neurons  Автор: RA McCutcheon · 2020 · Цитируется: 886 — The finding that antagonists of a specific glutamate receptor, the N‐methyl‐D‐aspartate (NMDA) receptor, induce psychotic symptoms has led to a wealth of  Автор: A Marsman · 2011 · Цитируется: 640 — Schizophrenia is a severe chronic psychiatric illness, characterized by hallucinations and delusions. Both were initially based on indirect evidence In this review, we study the evidence for dopaminergic dysfunction in schizophrenia, drawing data from neurochemical imaging studies. Автор: JM Stone · 2007 · Цитируется: 569 — We examine predictions made by the NMDA receptor hypofunction hypothesis and consider how they fit with current neurochemical findings in patients and animal  Glutamate-based theories of schizophrenia focus on dysfunction of brain glutamate systems, particularly NMDA receptors. Recent discoveries extend our  Автор: DC Javitt · 2021 — Citation. This review evaluates evidence from preclinical and clinical studies that brain glutamatergic neurotransmission is altered in schizophrenia, may affect symptom  Автор: W Hu · 2014 · Цитируется: 409 — A number of studies have indicated that antagonists of the N-methyl-d-aspartate (NMDA) subtypes of glutamate receptors can cause schizophrenia-like symptoms  For years people assumed hallucinations and delusions were the result of excess dopamine in the mesolimbic pathway. C. (2021). glutamate do in schizophrenia what is a leading hypothesis of schizophrenia schizophrenia treatment. Both were initially based on indirect  Автор: A Hasan · 2014 · Цитируется: 31 — To sum up, one could note that the glutamate hypothesis of schizophrenia is now well-established. These theories originated over 20  NMDAR hypofunction also underscores the need to consider mechanisms beyond dopamine dysfunction, given the limited effects of APs on negative  Автор: S Akhondzadeh · 1998 · Цитируется: 21 — Publication types. Both were initially based on indirect evidence from  As compared to dopaminergic agents, NMDA antagonists induce negative and cognitive symptoms of schizophrenia, as well as positive symptoms. neurotransmission  Автор: M Laruelle · 2003 · Цитируется: 662 — Preliminary imaging data compatible with this hypothesis have recently emerged. To date, the most widely considered neurochemical hypothesis of schizophrenia is the dopamine hypothesis, which postulates  Автор: P Seeman · 2009 · Цитируется: 101 — The treatment of schizophrenia for the last half century has been with dopamine (DA) D(2) receptor blockers, implicating a hyperdopamine basis for psychosis. Editorial ; MeSH terms. All current medications for schizophrenia function primarily by blocking dopamine D2 receptors, supporting the  Автор: YY Mei · 2018 · Цитируется: 93 — According to the glutamate hypothesis of schizophrenia, the abnormality of glutamate transmission induced by hypofunction of NMDA receptors (NMDARs) is  A number of studies have indicated that antagonists of the N-methyl-d-aspartate subtypes of glutamate receptors can cause schizophrenia-like  NMDAR hypofunction also underscores the need to consider mechanisms beyond dopamine dysfunction, given the limited effects of APs on negative  Автор: A de Bartolomeis · 2022 · Цитируется: 151 — According to these findings, a significant increase in plasma inflammatory markers has been found in schizophrenia patients compared to healthy  A number of studies have indicated that antagonists of the N-methyl-d-aspartate subtypes of glutamate receptors can cause schizophrenia-like  Glutamate-based theories of schizophrenia focus on dysfunction of brain glutamate systems, particularly NMDA receptors. Neurodevelopmental and neurodegenerative  Автор: JM Stone · 2011 · Цитируется: 102 — Growing evidence for glutamate abnormalities in schizophrenia support the development of novel antipsychotic agents targeting this system. These theories originated over 20  The dopamine hypothesis is supported by evidence that patients with schizophrenia have marked dopamine receptor and neurotransmitter  Автор: G Tsai · 2002 · Цитируется: 808 — Several clinical trials indicate agents that enhance NMDA receptor function via the glycine modulatory site reduce negative and variably improve cognitive  To date, the most widely considered neurochemical hypothesis of schizophrenia is the dopamine hypothesis, which postulates that symptoms of schizophrenia  Автор: DC Javitt · 2010 · Цитируется: 436 — Because glutamate/NMDA receptors are located throughout the brain, glutamatergic models predict widespread cortical dysfunction with particular involvement of  Автор: T Swanton · 2020 · Цитируется: 9 — “The Dopamine, Glutamate, and GABA Hypotheses of Schizophrenia: Glutamate May Be the Key ”. Decreased brain volumes have been observed in the disease,  Over the last 50 years, evidence for central involvement of glutamatergic neurotransmission in the pathophysiology of schizophrenia has  There's a rich history of research suggesting that glutamate may be involved in the pathogenesis of schizophrenia, with an increasing amount  The dopamine hypothesis of schizophrenia is the principal explanatory model of antipsychotic drug action. · Abstract. Over At present, there remain several hypotheses . ANU Undergraduate Research Journal 10 (1): 88-  Автор: J Kantrowitz · 2012 · Цитируется: 203 — Over the past 20 years, attention has turned increasingly to dysfunction of the brain glutamate system as a fundamental underlying pathophysiology in  Автор: F Iasevoli · 2014 · Цитируется: 67 — In particular, dysfunctions in glutamate and dopamine interactions have been regarded as possible molecular mechanisms involved in schizophrenia pathophysiology  Автор: G Tsai · 2002 · Цитируется: 808 — Several clinical trials indicate agents that enhance NMDA receptor function via the glycine modulatory site reduce negative and variably improve cognitive  The glutamate hypothesis of schizophrenia posits that reduced N-methyl-D-aspartate receptor (NMDAR) function contributes to the core cognitive  Professor Daniel Weinberger discusses evidence from a number of research areas that highlight the importance of the neurotransmitter glutamate in  Drugs that Target the Glutamate Synapse: Implications for the Glutamate Hypothesis of Schizophrenia dopamine. The NMDA receptor hypofunction hypothesis proposes that  Автор: SM Stahl · 2018 · Цитируется: 500 — Psychosis is now widely hypothesized to involve neural networks beyond the classical dopaminergic mesolimbic pathway, including serotonin and glutamate systems  Автор: DC Javitt · Цитируется: 780 — To date, the most widely considered neurochemical hypothesis of schizophrenia is the dopamine hypothesis, which postulates that symptoms of schizophrenia  Автор: O Howes · 2015 · Цитируется: 1130 — The glutamate and dopamine hypotheses are leading theories of the pathoaetiology of schizophrenia. Both were initially based on indirect  New approaches for treating all schizophrenia symptoms by modulating dopamine and glutamate in non-traditional ways. sao58, ns, 1ukm, yfe, 1yugis, r96hw2f, oy4n, qxx, vrk, 6dp,